Melanossp. z o.o. in liquidation
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2021-09-03
Share capital
5,000.00 PLN
Registered address
ul. Prof. Stanisława Łojasiewicza 4, 30-348 Kraków, Poland
Financials
Revenue history
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 3 of 4 financial statements were filed late (the longest delay 644 days for 2021).
- 2025not filed
- 202420/04/2026
- 202319/04/2024
- 202219/04/2024
- 202119/04/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Konrad Szczukiewicz – Liquidator
Marcin Marek Majka – Liquidator
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 14 | $189.09 | 14% | |
Marcin Marek Majkaage 54 | 78 | $1,053.48 | 78% |
Others | 8 | $108.05 | 8% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| May 15, 2024 | Call to creditors |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MedappS.A. | $3,351,163.61 | medapp.pl | ||
| EIT Rawmaterials Clc Eastsp. z o.o. | $1,795,803.10 | eitrawmaterials.eu | ||
| COS LabP.S.A. | $1,028,123.83 | coslab.pl | ||
| IntelliseqS.A. | $111,419.60 | intelliseq.pl | ||
| Przedsiębiorstwo Wielobranżowe Genezasp. z o.o. | $54,163.54 | geneza.eu | ||
| Medtransfersp. z o.o. | $21,666.01 | codete.com | ||
| Oncotherics PolandS.A. | $7,565.33 | oncotherics.com | ||
| Fusiomicasp. z o.o. | $5,263.98 | fusiomica.com | ||
| Ncage TherapeuticsS.A. | $29.14 | ncage.org | ||
| SelvitaS.A. | – | selvita.com |
Change history
| Date | Event | |
|---|---|---|
| 2023-08-28 | Name change (Melanos → Melanos Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2023-03-13 | Liquidation opened | |
| 2021-09-03 | Entered in the register |
FAQ
The main business activity of Melanos focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on September 3, 2021.
The headquarters is located at: ul. Prof. Stanisława Łojasiewicza 4, 30-348 Kraków.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-04-20